Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients-Reference-Cited by-同舟云学术

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Published:2012 Issue:1 Volume:127 Page:34-42
ISSN:1421-9662
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Meggyesi Nóra,Kozma András,Halm Gabriella,Nahajevszky Sarolta,Bátai Árpád,Fekete Sándor,Barta Anikó,Ujj György,Lueff Sándor,Sipos Andrea,Ádám Emma,Bors András,Reményi Péter,Masszi Tamás,Tordai Attila,Andrikovics Hajnalka

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Reference25 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia

3. P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia

4. Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib

5. Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review;Journal of Blood Medicine;2023-04

2. A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-04

3. Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells;Cell Proliferation;2023-02-27

4. Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution;Egyptian Journal of Medical Human Genetics;2022-03-06

5. T‐cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR‐ABL transcripts and t(10;11)(q11;p15);Journal of Clinical Laboratory Analysis;2020-02-13